ebastine has been researched along with Urticaria in 14 studies
Urticaria: A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ebastine is a new second generation histamine H1 receptor antagonist that has shown clinical efficacy in the treatment of seasonal and perennial allergic rhinitis and chronic urticaria after once-daily administration." | 9.08 | Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults. ( Kalis, B, 1996) |
| "Ebastine is safe and effective in preventing the symptoms of ACU." | 6.73 | Acquired cold urticaria symptoms can be safely prevented by ebastine. ( Magerl, M; Maurer, M; Metz, M; Schmolke, J; Siebenhaar, F; Zuberbier, T, 2007) |
| "Ebastine is a well-established secondgeneration oral H1-antihistamine that is administered once daily at a dose of 10-20 mg and is available both as a standard tablet and as a fast-dissolving tablet that disintegrates in the mouth." | 6.66 | Ebastine in the Treatment of Allergic Rhinitis and Urticaria: 30 Years of Clinical Studies and Real-World Experience. ( Sastre, J, 2020) |
| "Ebastine is a second-generation antihistamine which has been shown to be an effective treatment for both seasonal and perennial allergic rhinitis." | 6.44 | Ebastine in allergic rhinitis and chronic idiopathic urticaria. ( Sastre, J, 2008) |
| " Pruritus, number, diameter, duration and frequency of wheals, and adverse reactions were assessed." | 5.72 | Efficacy and safety of ebastine dose escalation in chronic urticaria: A prospective study. ( Chen, Q; Hao, F; Li, S; Qian, T; Song, Z; Zhang, D, 2022) |
| "Levocetirizine is the active enantiomer of cetirizine, a potent drug with little metabolism widely used for allergic rhinitis and urticaria." | 5.10 | A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects. ( DeVos, C; Grant, JA; Moulaert, B; Riethuisen, JM, 2002) |
| "Ebastine is a new second generation histamine H1 receptor antagonist that has shown clinical efficacy in the treatment of seasonal and perennial allergic rhinitis and chronic urticaria after once-daily administration." | 5.08 | Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults. ( Kalis, B, 1996) |
| " We report a patient with urticaria due to ingestion of ebastine and fexofenadine." | 3.77 | Urticaria due to antihistamines. ( Laguna Martínez, JJ; Reaño Martos, M; Rojas Pérez-Ezquerra, P; Sánchez Morillas, L; Sanz, ML, 2011) |
| "Ebastine is safe and effective in preventing the symptoms of ACU." | 2.73 | Acquired cold urticaria symptoms can be safely prevented by ebastine. ( Magerl, M; Maurer, M; Metz, M; Schmolke, J; Siebenhaar, F; Zuberbier, T, 2007) |
| "Ebastine was no better than placebo until 4 h, but was efficacious thereafter until 24 h." | 2.69 | A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects. ( Danielson, L; DeVos, C; Grant, JA; Rihoux, JP, 1999) |
| "Ebastine is a well-established secondgeneration oral H1-antihistamine that is administered once daily at a dose of 10-20 mg and is available both as a standard tablet and as a fast-dissolving tablet that disintegrates in the mouth." | 2.66 | Ebastine in the Treatment of Allergic Rhinitis and Urticaria: 30 Years of Clinical Studies and Real-World Experience. ( Sastre, J, 2020) |
| "Ebastine is a second-generation antihistamine which has been shown to be an effective treatment for both seasonal and perennial allergic rhinitis." | 2.44 | Ebastine in allergic rhinitis and chronic idiopathic urticaria. ( Sastre, J, 2008) |
| "Ebastine is a once-daily, non-sedating, selective, long-acting, second-generation antihistamine." | 2.42 | A review of the second-generation antihistamine ebastine for the treatment of allergic disorders. ( De Belder, T; Sys, L; Van Cauwenberge, P, 2004) |
| " Pruritus, number, diameter, duration and frequency of wheals, and adverse reactions were assessed." | 1.72 | Efficacy and safety of ebastine dose escalation in chronic urticaria: A prospective study. ( Chen, Q; Hao, F; Li, S; Qian, T; Song, Z; Zhang, D, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 8 (57.14) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, BA | 1 |
| Ali, A | 1 |
| Hosny, KM | 1 |
| Halwani, AA | 1 |
| Almehmady, AM | 1 |
| Iqbal, M | 1 |
| Alharbi, WS | 1 |
| Abualsunun, WA | 1 |
| Bakhaidar, RB | 1 |
| Murshid, SSA | 1 |
| Khan, MK | 1 |
| Qian, T | 1 |
| Li, S | 1 |
| Chen, Q | 1 |
| Zhang, D | 1 |
| Song, Z | 1 |
| Hao, F | 1 |
| Sastre, J | 2 |
| Izumi, N | 1 |
| Mizuguchi, H | 1 |
| Umehara, H | 1 |
| Ogino, S | 1 |
| Fukui, H | 1 |
| Magerl, M | 2 |
| Schmolke, J | 2 |
| Metz, M | 2 |
| Zuberbier, T | 2 |
| Siebenhaar, F | 2 |
| Maurer, M | 2 |
| Sánchez Morillas, L | 1 |
| Rojas Pérez-Ezquerra, P | 1 |
| Reaño Martos, M | 1 |
| Sanz, ML | 1 |
| Laguna Martínez, JJ | 1 |
| Van Cauwenberge, P | 1 |
| De Belder, T | 1 |
| Sys, L | 1 |
| Cadahía, A | 1 |
| Cardona, V | 1 |
| Guilarte, M | 1 |
| Muñoz-Cano, R | 1 |
| Kalis, B | 1 |
| Grant, JA | 2 |
| Danielson, L | 1 |
| Rihoux, JP | 1 |
| DeVos, C | 2 |
| Riethuisen, JM | 1 |
| Moulaert, B | 1 |
3 reviews available for ebastine and Urticaria
| Article | Year |
|---|---|
Ebastine in the Treatment of Allergic Rhinitis and Urticaria: 30 Years of Clinical Studies and Real-World Experience.
Topics: Administration, Oral; Butyrophenones; Histamine; Histamine H1 Antagonists; Humans; Piperidines; Rhin | 2020 |
Ebastine in allergic rhinitis and chronic idiopathic urticaria.
Topics: Animals; Butyrophenones; Chronic Disease; Histamine H1 Antagonists; Humans; Piperidines; Rhinitis, A | 2008 |
A review of the second-generation antihistamine ebastine for the treatment of allergic disorders.
Topics: Anti-Allergic Agents; Asthma; Butyrophenones; Clinical Trials as Topic; Histamine H1 Antagonists, No | 2004 |
5 trials available for ebastine and Urticaria
| Article | Year |
|---|---|
Prevention of signs and symptoms of dermographic urticaria by single-dose ebastine 20 mg.
Topics: Adult; Affect; Aged; Butyrophenones; Cognition; Cross-Over Studies; Double-Blind Method; Female; His | 2009 |
Acquired cold urticaria symptoms can be safely prevented by ebastine.
Topics: Adult; Affect; Butyrophenones; Cold Temperature; Cross-Over Studies; Double-Blind Method; Female; Hi | 2007 |
Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults.
Topics: Adult; Anti-Allergic Agents; Butyrophenones; Chronic Disease; Double-Blind Method; Histamine H1 Anta | 1996 |
A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects.
Topics: Adult; Butyrophenones; Cetirizine; Cross-Over Studies; Dibenzazepines; Double-Blind Method; Histamin | 1999 |
A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
Topics: Adult; Benzimidazoles; Butyrophenones; Cetirizine; Cross-Over Studies; Double-Blind Method; Histamin | 2002 |
6 other studies available for ebastine and Urticaria
| Article | Year |
|---|---|
Carbopol emulgel loaded with ebastine for urticaria: development, characterization,
Topics: Acrylic Resins; Administration, Cutaneous; Animals; Butyrophenones; Chemistry, Pharmaceutical; Disea | 2022 |
Efficacy and safety of ebastine dose escalation in chronic urticaria: A prospective study.
Topics: Butyrophenones; Cholinergic Agents; Chronic Disease; Chronic Urticaria; Headache; Histamine H1 Antag | 2022 |
Analysis of disease-dependent sedative profiles of H(1)-antihistamines by large-scale surveillance using the visual analog scale.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Asthma; Butyrophenones; Cetirizine; Child; Chlorpheniram | 2008 |
Urticaria due to antihistamines.
Topics: Administration, Oral; Butyrophenones; Diagnosis, Differential; Drug Hypersensitivity; Female; Histam | 2011 |
[Antihistamines. How safe are they?].
Topics: Butyrophenones; Electrocardiography; Histamine H1 Antagonists; Humans; Piperidines; Rhinitis, Allerg | 2002 |
Safety of ebastine.
Topics: Arrhythmias, Cardiac; Butyrophenones; Histamine H1 Antagonists; Humans; Piperidines; Rhinitis; Treat | 2005 |